Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Debt (2020 - 2023)

Candel Therapeutics' Total Debt history spans 4 years, with the latest figure at $20.4 million for Q3 2023.

  • For Q3 2023, Total Debt rose 1.58% year-over-year to $20.4 million; the TTM value through Sep 2023 reached $20.4 million, up 1.58%, while the annual FY2022 figure was $20.2 million, 3507.5% up from the prior year.
  • Total Debt for Q3 2023 was $20.4 million at Candel Therapeutics, roughly flat from $20.4 million in the prior quarter.
  • Across five years, Total Debt topped out at $20.4 million in Q3 2023 and bottomed at $463000.0 in Q4 2020.
  • The 4-year median for Total Debt is $20.1 million (2022), against an average of $15.8 million.
  • The largest annual shift saw Total Debt skyrocketed 3507.5% in 2022 before it grew 1.58% in 2023.
  • A 4-year view of Total Debt shows it stood at $463000.0 in 2020, then rose by 20.95% to $560000.0 in 2021, then surged by 3507.5% to $20.2 million in 2022, then grew by 1.17% to $20.4 million in 2023.
  • Per Business Quant, the three most recent readings for CADL's Total Debt are $20.4 million (Q3 2023), $20.4 million (Q2 2023), and $20.3 million (Q1 2023).